288569-83-5 Usage
General Description
1,2-Ethanediol,1-(3-pyridinyl)-,(1R)-(9CI) is a chemical compound that is also known as 1-(3-pyridinyl)ethane-1,2-diol. It is a chiral compound with a single stereocenter and a molecular formula of C7H9NO2. 1,2-Ethanediol,1-(3-pyridinyl)-,(1R)-(9CI) is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and fine chemicals due to its versatile reactivity and ability to form complex molecular structures. Additionally, it is also used as a reagent in organic synthesis and as a precursor for the production of glycol-based polymers and resins. The stereochemistry of this compound indicates that it has a specific orientation of its chemical groups, which can impact its biological activity and interactions with other molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 288569-83-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,8,5,6 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 288569-83:
(8*2)+(7*8)+(6*8)+(5*5)+(4*6)+(3*9)+(2*8)+(1*3)=215
215 % 10 = 5
So 288569-83-5 is a valid CAS Registry Number.
288569-83-5Relevant articles and documents
Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same
-
, (2008/06/13)
It is an objective to produce intermediates of optically active beta-3 adrenaline receptor agonists from readily available raw materials in a safe, efficient and industrially advantageous manner. A substituted acetylpyridine derivative represented by the general formula (9) is reduced by enantioselective reduction to produce an optically active hydroxyethyl derivative represented by the general formula (10) (wherein * represents an asymmetric carbon atom), and it is further derivatized to an intermediate of an optically active beta-3 adrenaline receptor agonist, such as an optically active dihydroxyethylpyridine derivative represented by the general formula (14) or an optically active oxirane derivative represented by the general formula (16).
